Circon Buys Cabot
Executive SummaryCircon gains a strong presence in physician-office OB/GYN and urology markets. Cabot links up with a technology leader that will help get its products into a number of other clinical areas.
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.